logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Protocol
|
Research Protocol

Survey of Plasmodium falciparum sulfadoxine/pyrimethamine (SP) resistance markers in MSF projects in North and South Kivu, DR Congo

de Wit MBK, Rao B, Lassovski M, Ouabo A, Badjo C,  et al.
2018-07-01
2018-07-01
Primary Objective: To measure the prevalence of molecular markers of SP resistant malaria in North and South Kivu, DRC.

Sulfadoxine/pyrimethamine (SP) forms the backbone of mos...
Journal Article
|
Research

In vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo

de Wit MBK, Funk A, Moussally K, Nkuba DA, Siddiqui R,  et al.
2016-09-06 • Malaria Journal
2016-09-06 • Malaria Journal
BACKGROUND
Between 2009 and 2012, malaria cases diagnosed in a Médecins sans Frontières programme have increased fivefold in Baraka, South Kivu, Democratic Republic of the Congo (DRC...
Protocol
|
Research Protocol

Efficacy of amodiaquine-artesunate and artemether-lumefantrine for the treatment of uncomplicated childhood plasmodium falciparum malaria

de Wit MBK
2014-06-01
2014-06-01
PRIMARY OBJECTIVES of study:
To compare the in vivo efficacy of artesunate-amodiaquine (ASAQ) versus artemether-lumefantrine (Coartem®) in a population of children aged between 6 an...
Journal Article
|
Research

Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis

WorldWide Antimalarial Resistance Network Methodology Study Group, Dahal P, Simpson JA, Abdulla S, Achan J,  et al.
2019-07-05 • Malaria Journal
2019-07-05 • Malaria Journal
BACKGROUND
Therapeutic efficacy studies in uncomplicated Plasmodium falciparum malaria are confounded by new infections, which constitute competing risk events since they can potenti...